Gang Li Selected Research

antagomir-429

12/2018

MiR-429 improved the hypoxia tolerance of human amniotic cells by targeting HIF-1α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gang Li Research Topics

Disease

473	Neoplasms (Cancer) 05/2024 - 02/2002
107	Glioma (Gliomas) 11/2023 - 02/2003
99	Infections 03/2024 - 12/2002
87	Inflammation (Inflammations) 01/2024 - 11/2004
70	Neoplasm Metastasis (Metastasis) 05/2024 - 02/2002
59	Melanoma (Melanoma, Malignant) 12/2021 - 02/2002
52	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2004
50	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 08/2008
48	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 06/2002
48	Carcinogenesis 11/2023 - 02/2003
45	Stomach Neoplasms (Stomach Cancer) 04/2024 - 10/2006
42	Wounds and Injuries (Trauma) 04/2024 - 06/2003
40	Hypoxia (Hypoxemia) 10/2024 - 06/2010
36	Fibrosis (Cirrhosis) 12/2023 - 11/2004
34	Carcinoma (Carcinomatosis) 03/2024 - 06/2002
33	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 09/2004
30	Lung Neoplasms (Lung Cancer) 10/2023 - 03/2002
29	Stroke (Strokes) 04/2024 - 01/2008
26	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 05/2009
26	Urinary Bladder Neoplasms (Bladder Cancer) 08/2023 - 09/2002
24	Hypertension (High Blood Pressure) 11/2022 - 03/2008
24	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 09/2003
23	Insulin Resistance 01/2023 - 08/2003
22	Pancreatitis 04/2024 - 01/2006
22	Obesity 09/2023 - 07/2007
21	Pain (Aches) 04/2024 - 02/2011
21	COVID-19 04/2024 - 01/2020
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2011
21	Body Weight (Weight, Body) 01/2023 - 04/2006
21	Nasopharyngeal Carcinoma 01/2020 - 03/2004
20	Non-alcoholic Fatty Liver Disease 04/2024 - 08/2017
20	Sepsis (Septicemia) 01/2023 - 09/2013
19	Hemorrhage 02/2024 - 02/2010
19	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 12/2007
19	Heart Failure 02/2024 - 08/2005
19	Cognitive Dysfunction 10/2023 - 12/2013
19	Adenocarcinoma 04/2023 - 11/2009
18	Osteoarthritis 04/2024 - 06/2015
18	Osteoporosis 04/2024 - 06/2011
18	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023 - 11/2009
17	Myocardial Infarction 12/2023 - 01/2013
17	Infarction (Infarctions) 12/2023 - 06/2008
17	Ischemia 10/2023 - 04/2009
17	Spinal Cord Injuries (Spinal Cord Injury) 09/2023 - 10/2003
16	Hemophilia A (Haemophilia) 01/2023 - 02/2014
16	Atherosclerosis 01/2023 - 09/2009
15	Pulmonary Arterial Hypertension 10/2024 - 04/2012
15	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 02/2010
15	Chronic Hepatitis B 02/2016 - 08/2008
14	Ischemic Stroke 04/2024 - 01/2015
14	Rheumatoid Arthritis 11/2023 - 02/2010
14	Cerebral Infarction 01/2023 - 01/2013
13	Thrombosis (Thrombus) 04/2024 - 08/2015
13	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 12/2004
13	Reperfusion Injury 02/2024 - 01/2014
13	Type 2 Diabetes Mellitus (MODY) 01/2024 - 04/2011

Drug/Important Bio-Agent (IBA)

209	Proteins (Proteins, Gene)FDA Link 03/2024 - 12/2002
130	Biomarkers (Surrogate Marker)IBA 05/2024 - 12/2007
78	MicroRNAs (MicroRNA)IBA 02/2023 - 01/2012
53	Messenger RNA (mRNA)IBA 03/2024 - 11/2003
51	CytokinesIBA 09/2023 - 02/2002
46	Long Noncoding RNAIBA 10/2024 - 12/2014
41	Small Interfering RNA (siRNA)IBA 05/2024 - 03/2004
40	Therapeutic UsesIBA 04/2024 - 01/2010
38	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 04/2003
33	EnzymesIBA 11/2022 - 12/2005
32	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2006
30	Peptides (Polypeptides)IBA 04/2024 - 05/2005
27	RNA (Ribonucleic Acid)IBA 10/2023 - 12/2002
25	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2004
24	LipidsIBA 05/2024 - 04/2007
24	Interleukin-6 (Interleukin 6)IBA 05/2024 - 02/2003
23	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 06/2005
22	AntigensIBA 01/2022 - 03/2002
21	Neuroprotective AgentsIBA 03/2024 - 10/2010
20	Phosphotransferases (Kinase)IBA 04/2024 - 01/2013
20	CateninsIBA 02/2024 - 09/2012
20	CollagenIBA 03/2023 - 06/2004
20	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 05/2005
19	LigandsIBA 02/2023 - 05/2005
18	AntioxidantsIBA 02/2024 - 04/2008
17	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 10/2014
17	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 11/2012
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2023 - 11/2004
16	VaccinesIBA 05/2024 - 06/2004
16	Circular RNAIBA 08/2023 - 01/2019
16	Transcription Factors (Transcription Factor)IBA 01/2022 - 09/2003
15	Caspase 3 (Caspase-3)IBA 03/2023 - 12/2004
14	Antiviral Agents (Antivirals)IBA 11/2023 - 06/2009
14	CholesterolIBA 01/2023 - 04/2009
14	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 06/2002
13	LipopolysaccharidesIBA 01/2023 - 01/2004

Therapy/Procedure

220	Therapeutics 05/2024 - 09/2002
61	Drug Therapy (Chemotherapy) 05/2024 - 07/2004
29	Immunotherapy 02/2024 - 06/2004
25	Radiotherapy 04/2024 - 04/2005
22	Stents 01/2024 - 05/2009
19	Transplantation 04/2024 - 05/2006
15	Aftercare (After-Treatment) 04/2024 - 06/2002
15	Length of Stay 09/2023 - 10/2013